Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein

被引:7
|
作者
Kellershohn, N [1 ]
Laurent, M [1 ]
机构
[1] Univ Paris Sud, Serv Imagerie Cellulaire, URA D2227 CNRS, Ctr Orsay, F-91405 Orsay, France
关键词
D O I
10.1042/bj3340539
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases are thought to result from the conformational change of the normal cellular prion protein to a pathogenic protease-resistant isoform. However, brain extracts not containing the protease-resistant isoform of the prion protein can be infectious following interspecies transmission. The 'protein-only' hypothesis of pathogenesis is extended to provide possible explanations which could be interpreted in terms of a different infectious agent. It is proposed that normal cellular protein (PrPC) may be transformed into a form (PrP*) that is conformationally distinct from the host-specific abnormal isoform (PrPSc). In infection from a heterologous donor, the dimeric forms of heterologous PrPSc, which may catalyse the formation: of host PrP* from PrPC, host PrP* and host PrPSc are all considered to be capable of catalysing, to some extent, the conversion of PrPC into PrPSc. However. depending on the species involved, PrP* may, or may not, be pathogenic, and may. or map not, be sensitive to proteolysis. It is shown: by numerical integration of the differential rate equations derived from this model, that a strain map be stabilized after two or three passages through a different species and that transmission might occur in the absence of detectable protease-resistant prion protein. The natural transmission of scrapie to cattle is discussed in relation to the model.
引用
收藏
页码:539 / 545
页数:7
相关论文
共 50 条
  • [21] Prionics or The kinetic basis of prion diseases
    Eigen, M
    BIOPHYSICAL CHEMISTRY, 1996, 63 (01) : A1 - A18
  • [22] Comparative Conformational Dynamics of Cellular Prion Proteins Towards Elucidating the Species Barrier
    Hamada, Robyn
    Woo, Jesse
    Shikiya, Ronald
    Soto, Patricia
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 534A - 534A
  • [23] Seeded Fibrillation as Molecular Basis of the Species Barrier in Human Prion Diseases
    Luers, Lars
    Bannach, Oliver
    Stoehr, Jan
    Woerdehoff, Michael Marius
    Wolff, Martin
    Nagel-Steger, Luitgard
    Riesner, Detlev
    Willbold, Dieter
    Birkmann, Eva
    PLOS ONE, 2013, 8 (08):
  • [24] Protein misfolding and prion diseases
    Cohen, FE
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (02) : 313 - 320
  • [25] Prion protein interaction with nucleic acids: Possible models for prion diseases and prion function
    Grossman, A
    Zeiler, B
    Adler, V
    Kryukov, V
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S71 - S71
  • [26] Conformational dynamics of the cellular prion protein
    Soto, Patricia
    Bui, Natalie
    Carter, Margaret
    Gonzales, Roger
    Graft, William
    Lax, Angela
    Nieri, Chad
    Zhao, Bo
    Bartz, Jason
    PRION, 2015, 9 : S22 - S23
  • [27] Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases
    Villar-Pique, Anna
    Schmitz, Matthias
    Lachmann, Ingolf
    Karch, Andre
    Calero, Olga
    Stehmann, Christiane
    Sarros, Shannon
    Ladogana, Anna
    Poleggi, Anna
    Santana, Isabel
    Ferrer, Isidre
    Mitrova, Eva
    Zakova, Dana
    Pocchiari, Maurizio
    Baldeiras, Ines
    Calero, Miguel
    Collins, Steven J.
    Geschwind, Michael D.
    Sanchez-Valle, Raquel
    Zerr, Inga
    Llorens, Franc
    MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2811 - 2821
  • [28] Cellular prion protein neuroprotective function: implications in prion diseases
    Roucou, X
    LeBlanc, AC
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (01): : 3 - 11
  • [29] Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases
    Kovacs, GG
    Voigtländer, T
    Hainfellner, JA
    Budka, H
    ACTA NEUROPATHOLOGICA, 2002, 104 (03) : 320 - 326
  • [30] Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases
    Anna Villar-Piqué
    Matthias Schmitz
    Ingolf Lachmann
    André Karch
    Olga Calero
    Christiane Stehmann
    Shannon Sarros
    Anna Ladogana
    Anna Poleggi
    Isabel Santana
    Isidre Ferrer
    Eva Mitrova
    Dana Žáková
    Maurizio Pocchiari
    Inês Baldeiras
    Miguel Calero
    Steven J. Collins
    Michael D. Geschwind
    Raquel Sánchez-Valle
    Inga Zerr
    Franc Llorens
    Molecular Neurobiology, 2019, 56 : 2811 - 2821